Usha Praturi

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial

Raches Ella, Siddharth Reddy, Harsh Jogdand et al. · The Lancet Infectious Diseases · 2021 · 365 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Protective efficacy of Zika vaccine in AG129 mouse model

K. Sumathy, Bharathi Kulkarni, Ravi Kumar Gondu et al. · Scientific Reports · 2017 · 102 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

Safety and immunogenicity clinical trial of an inactivated SARS-CoV-2 vaccine, BBV152 (a phase 2, double-blind, randomised controlled trial) and the persistence of immune responses from a phase 1 follow-up report

Raches Ella, Siddharth Reddy, Harsh Jogdand et al. · medRxiv · 2020 · 38 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17